January 15, 2025
December 10, 2024 - Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional). See NOFO RFA-RM-24-010.
Office of Strategic Coordination (Common Fund)
The purpose of this notice is to change the new application receipt date and expiration date for Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional) RFA-RM-24-010. The new application receipt date is March 18, 2025. The new expiration date: March 19, 2025. Changes to the Notice of Funding Opportunity (NOFO) are shown below.
This notice extends the expiration date for the following funding opportunity:
.
Application Due Dates |
Review and Award Cycles |
||||
New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
March 18, 2025 per issuance of NOT-RM-25-001. (Previous Date: February 28, 2025) | Not Applicable | Not Applicable | July 2025 | October 2025 | December 2025 |
Expiration Date: March 19, 2025 per issuance of NOT-RM-25-001. (Previous Expiration Date: March 1, 2025).
All other aspects of the opportunity(ies) remain the same.
Please direct all inquiries to:
Christine Happel, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 240-472-7550
Email: [email protected]
Inquiries may also be directed to: [email protected]